June 15, 2024

Immunoassay Market Size To Cross USD 51.33 Bn By 2032

The global immunoassay market size accounted for US$ 32.46 Bn in 2022 and is projected to reach around USD 51.33 Bn by 2032, growing at a CAGR of 4.68% from 2023 to 2032.

Immunoassay Market Size 2023 To 2032 - Precedence Statistics

Report Summary

The global immunoassay market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the immunoassay market across the globe.

A comprehensive estimate on the immunoassay market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of immunoassay during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2557

Immunoassay Market Report Scope 

Report CoverageDetails
Market Size in 2023USD 33.98 Billion
Market Size by 2032USD 51.33 Billion
Growth Rate from 2023 to 2032CAGR of 4.68%
Largest MarketNorth America
Fastest Growing MarketAsia Pacific
Base Year2022
Forecast Period2023 to 2032
Segments CoveredBy Product, By Technology, By Specimen, By Application and By End User

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized immunoassay market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Sensor Market Size To Cross USD 508.64 Bn By 2032

Immunoassay Market Players

The report includes the profiles of key immunoassay market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

  • Abbott Laboratories
  • Danaher Corporation (Beckman Coulter)
  • Quidel Corporation
  • Ortho Clinical Diagnostics
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson, and Company
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific, Inc.
  • Siemens Healthinners

Market Segmentation

By Product

  • Reagents & Kits
    • ELISA Reagents & Kits
    • Rapid Test Reagent & Kits
    • ELISpot Reagents & Kits
    • Western Blot Reagents & Kits
    • Other Reagents & Kits
  • Analyzer
    • By Type
      • Open-ended System
      • Closed-Ended System
    • By Purchased Mode
      • Rental Purchased
      • Outright Purchased
  • Software and Services

By Technology

  • ELISA
    • By generation
      • Third generation & Above
      • Second-generation & Below
  • Rapid Tests
  • ELISpot
  • Western Blotting
  • Radioimmunoassay
  • Other technologies

By Specimen

  • Blood
  • Saliva
  • Urine
  • Other Specimen

By Application

  • Infectious diseases
  • Endocrinology
  • Oncology
  • Bone and mineral disorders
  • Cardiology
  • Blood screening
  • Autoimmune Disorders
  • Allergy Diagnostics
  • Toxicology
  • Newborn Screening
  • Other Application

By End-User

  • Hospitals & Clinics
  • Clinical Laboratories
  • Pharmaceutical & Biotechnology Companies And Cro
  • Blood Banks
  • Research & Academic Laboratories
  • Home Care Setting

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Immunoassay Market 

5.1. COVID-19 Landscape: Immunoassay Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Immunoassay Market, By Product

8.1. Immunoassay Market, by Product, 2023-2032

8.1.1. Reagents & Kits

8.1.1.1. Market Revenue and Forecast (2023-2032)

8.1.2. Analyzer

8.1.2.1. Market Revenue and Forecast (2023-2032)

8.1.3. Software and Services

8.1.3.1. Market Revenue and Forecast (2023-2032)

Chapter 9. Global Immunoassay Market, By Technology

9.1. Immunoassay Market, by Technology, 2023-2032

9.1.1. ELISA

9.1.1.1. Market Revenue and Forecast (2023-2032)

9.1.2. Rapid Tests

9.1.2.1. Market Revenue and Forecast (2023-2032)

9.1.3. ELISpot

9.1.3.1. Market Revenue and Forecast (2023-2032)

9.1.4. Western Blotting

9.1.4.1. Market Revenue and Forecast (2023-2032)

9.1.5. Radioimmunoassay

9.1.5.1. Market Revenue and Forecast (2023-2032)

9.1.6. Other technologies

9.1.5.1. Market Revenue and Forecast (2023-2032)

Chapter 10. Global Immunoassay Market, By Specimen 

10.1. Immunoassay Market, by Specimen, 2023-2032

10.1.1. Blood

10.1.1.1. Market Revenue and Forecast (2023-2032)

10.1.2. Saliva

10.1.2.1. Market Revenue and Forecast (2023-2032)

10.1.3. Urine

10.1.3.1. Market Revenue and Forecast (2023-2032)

10.1.4. Other Specimen

10.1.4.1. Market Revenue and Forecast (2023-2032)

Chapter 11. Global Immunoassay Market, By Application

11.1. Immunoassay Market, by Application, 2023-2032

11.1.1. Infectious diseases

11.1.1.1. Market Revenue and Forecast (2023-2032)

11.1.2. Endocrinology

11.1.2.1. Market Revenue and Forecast (2023-2032)

11.1.3. Oncology

11.1.3.1. Market Revenue and Forecast (2023-2032)

11.1.4. Bone and mineral disorders

11.1.4.1. Market Revenue and Forecast (2023-2032)

11.1.5. Cardiology

11.1.5.1. Market Revenue and Forecast (2023-2032)

11.1.6. Blood screening

11.1.6.1. Market Revenue and Forecast (2023-2032)

11.1.7. Autoimmune Disorders

11.1.7.1. Market Revenue and Forecast (2023-2032)

11.1.8. Allergy Diagnostics

11.1.8.1. Market Revenue and Forecast (2023-2032)

11.1.9. Toxicology

11.1.9.1. Market Revenue and Forecast (2023-2032)

11.1.10. Newborn Screening

11.1.10.1. Market Revenue and Forecast (2023-2032)

11.1.11. Other Application

11.1.11.1. Market Revenue and Forecast (2023-2032)

Chapter 12. Global Immunoassay Market, By End-User

12.1. Immunoassay Market, by End-User, 2023-2032

12.1.1. Hospitals & Clinics

12.1.1.1. Market Revenue and Forecast (2023-2032)

12.1.2. Clinical Laboratories

12.1.2.1. Market Revenue and Forecast (2023-2032)

12.1.3. Pharmaceutical & Biotechnology Companies And Cro

12.1.3.1. Market Revenue and Forecast (2023-2032)

12.1.4. Blood Banks

12.1.4.1. Market Revenue and Forecast (2023-2032)

12.1.5. Research & Academic Laboratories

12.1.5.1. Market Revenue and Forecast (2023-2032)

12.1.6. Home Care Setting

12.1.6.1. Market Revenue and Forecast (2023-2032)

Chapter 13. Global Immunoassay Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product (2023-2032)

13.1.2. Market Revenue and Forecast, by Technology (2023-2032)

13.1.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.1.4. Market Revenue and Forecast, by Application (2023-2032)

13.1.5. Market Revenue and Forecast, by End-User (2023-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product (2023-2032)

13.1.6.2. Market Revenue and Forecast, by Technology (2023-2032)

13.1.6.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.1.6.4. Market Revenue and Forecast, by Application (2023-2032)

13.1.6.5. Market Revenue and Forecast, by End-User (2023-2032)

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product (2023-2032)

13.1.7.2. Market Revenue and Forecast, by Technology (2023-2032)

13.1.7.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.1.7.4. Market Revenue and Forecast, by Application (2023-2032)

13.1.7.5. Market Revenue and Forecast, by End-User (2023-2032)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product (2023-2032)

13.2.2. Market Revenue and Forecast, by Technology (2023-2032)

13.2.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.2.4. Market Revenue and Forecast, by Application (2023-2032)

13.2.5. Market Revenue and Forecast, by End-User (2023-2032)

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product (2023-2032)

13.2.6.2. Market Revenue and Forecast, by Technology (2023-2032)

13.2.6.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.2.7. Market Revenue and Forecast, by Application (2023-2032)

13.2.8. Market Revenue and Forecast, by End-User (2023-2032)

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product (2023-2032)

13.2.9.2. Market Revenue and Forecast, by Technology (2023-2032)

13.2.9.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.2.10. Market Revenue and Forecast, by Application (2023-2032)

13.2.11. Market Revenue and Forecast, by End-User (2023-2032)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product (2023-2032)

13.2.12.2. Market Revenue and Forecast, by Technology (2023-2032)

13.2.12.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.2.12.4. Market Revenue and Forecast, by Application (2023-2032)

13.2.13. Market Revenue and Forecast, by End-User (2023-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product (2023-2032)

13.2.14.2. Market Revenue and Forecast, by Technology (2023-2032)

13.2.14.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.2.14.4. Market Revenue and Forecast, by Application (2023-2032)

13.2.15. Market Revenue and Forecast, by End-User (2023-2032)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product (2023-2032)

13.3.2. Market Revenue and Forecast, by Technology (2023-2032)

13.3.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.3.4. Market Revenue and Forecast, by Application (2023-2032)

13.3.5. Market Revenue and Forecast, by End-User (2023-2032)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product (2023-2032)

13.3.6.2. Market Revenue and Forecast, by Technology (2023-2032)

13.3.6.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.3.6.4. Market Revenue and Forecast, by Application (2023-2032)

13.3.7. Market Revenue and Forecast, by End-User (2023-2032)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product (2023-2032)

13.3.8.2. Market Revenue and Forecast, by Technology (2023-2032)

13.3.8.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.3.8.4. Market Revenue and Forecast, by Application (2023-2032)

13.3.9. Market Revenue and Forecast, by End-User (2023-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product (2023-2032)

13.3.10.2. Market Revenue and Forecast, by Technology (2023-2032)

13.3.10.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.3.10.4. Market Revenue and Forecast, by Application (2023-2032)

13.3.10.5. Market Revenue and Forecast, by End-User (2023-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product (2023-2032)

13.3.11.2. Market Revenue and Forecast, by Technology (2023-2032)

13.3.11.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.3.11.4. Market Revenue and Forecast, by Application (2023-2032)

13.3.11.5. Market Revenue and Forecast, by End-User (2023-2032)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product (2023-2032)

13.4.2. Market Revenue and Forecast, by Technology (2023-2032)

13.4.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.4.4. Market Revenue and Forecast, by Application (2023-2032)

13.4.5. Market Revenue and Forecast, by End-User (2023-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product (2023-2032)

13.4.6.2. Market Revenue and Forecast, by Technology (2023-2032)

13.4.6.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.4.6.4. Market Revenue and Forecast, by Application (2023-2032)

13.4.7. Market Revenue and Forecast, by End-User (2023-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product (2023-2032)

13.4.8.2. Market Revenue and Forecast, by Technology (2023-2032)

13.4.8.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.4.8.4. Market Revenue and Forecast, by Application (2023-2032)

13.4.9. Market Revenue and Forecast, by End-User (2023-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product (2023-2032)

13.4.10.2. Market Revenue and Forecast, by Technology (2023-2032)

13.4.10.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.4.10.4. Market Revenue and Forecast, by Application (2023-2032)

13.4.10.5. Market Revenue and Forecast, by End-User (2023-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product (2023-2032)

13.4.11.2. Market Revenue and Forecast, by Technology (2023-2032)

13.4.11.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.4.11.4. Market Revenue and Forecast, by Application (2023-2032)

13.4.11.5. Market Revenue and Forecast, by End-User (2023-2032)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product (2023-2032)

13.5.2. Market Revenue and Forecast, by Technology (2023-2032)

13.5.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.5.4. Market Revenue and Forecast, by Application (2023-2032)

13.5.5. Market Revenue and Forecast, by End-User (2023-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product (2023-2032)

13.5.6.2. Market Revenue and Forecast, by Technology (2023-2032)

13.5.6.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.5.6.4. Market Revenue and Forecast, by Application (2023-2032)

13.5.7. Market Revenue and Forecast, by End-User (2023-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product (2023-2032)

13.5.8.2. Market Revenue and Forecast, by Technology (2023-2032)

13.5.8.3. Market Revenue and Forecast, by Specimen (2023-2032)

13.5.8.4. Market Revenue and Forecast, by Application (2023-2032)

13.5.8.5. Market Revenue and Forecast, by End-User (2023-2032)

Chapter 14. Company Profiles

14.1. Abbott Laboratories

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Danaher Corporation (Beckman Coulter)

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Quidel Corporation

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Ortho Clinical Diagnostics

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Sysmex Corporation

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Bio-Rad Laboratories, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Becton, Dickinson, and Company

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. F. Hoffmann-La Roche AG

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Thermo Fisher Scientific, Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Siemens Healthinners

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com